Michael Alford

8.6k total citations · 2 hit papers
50 papers, 6.9k citations indexed

About

Michael Alford is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Michael Alford has authored 50 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 19 papers in Cellular and Molecular Neuroscience and 16 papers in Pharmacology. Recurrent topics in Michael Alford's work include Alzheimer's disease research and treatments (39 papers), Neuroscience and Neuropharmacology Research (16 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Michael Alford is often cited by papers focused on Alzheimer's disease research and treatments (39 papers), Neuroscience and Neuropharmacology Research (16 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Michael Alford collaborates with scholars based in United States, Italy and France. Michael Alford's co-authors include Eliezer Masliah, Lawrence A. Hansen, Margaret Mallory, Richard DeTeresa, Robert D. Terry, L. J. Thal, Jody Corey‐Bloom, Edward Rockenstein, Pietro Tiraboschi and David P. Salmon and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Michael Alford

50 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Lewy body variant of Alzheimer's disease

1990 873 citations Lawrence A. Hansen, David P. Salmon et al. Neurology profile →
Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease

2001 561 citations Eliezer Masliah, Margaret Mallory et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Alford United States	39	4.2k	2.5k	1.9k	1.6k	1.3k	50	6.9k
Christine Hulette United States	33	4.0k 1.0×	1.8k 0.7×	2.8k 1.4×	978 0.6×	1.2k 0.9×	54	7.6k
Jeffy P. Jimenez United States	3	5.8k 1.4×	2.1k 0.8×	2.8k 1.5×	771 0.5×	2.2k 1.7×	5	8.4k
B. T. Hyman United States	18	2.7k 0.6×	1.4k 0.6×	1.9k 1.0×	920 0.6×	922 0.7×	33	5.2k
P. C. Gaskell United States	23	6.3k 1.5×	2.1k 0.8×	3.7k 2.0×	1.0k 0.7×	1.7k 1.3×	45	10.7k
Carol F. Lippa United States	41	3.2k 0.8×	1.1k 0.4×	1.4k 0.8×	2.2k 1.4×	1.0k 0.8×	127	5.8k
Dorothée Abramowski Switzerland	32	5.4k 1.3×	2.5k 1.0×	3.3k 1.7×	970 0.6×	1.8k 1.3×	48	7.8k
Michael Hutton United States	48	5.3k 1.3×	1.8k 0.7×	2.9k 1.5×	2.6k 1.7×	1.9k 1.4×	107	8.2k
Lucia I. Sue United States	53	5.1k 1.2×	1.8k 0.7×	2.3k 1.2×	3.9k 2.5×	2.1k 1.5×	127	9.9k
Naruhiko Sahara Japan	42	5.0k 1.2×	1.9k 0.7×	2.8k 1.5×	1.1k 0.7×	1.6k 1.2×	157	7.2k
Judes Poirier Canada	48	5.1k 1.2×	1.5k 0.6×	2.8k 1.5×	580 0.4×	1.3k 1.0×	170	8.9k

Countries citing papers authored by Michael Alford

Since Specialization

Citations

This map shows the geographic impact of Michael Alford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Alford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Alford more than expected).

Fields of papers citing papers by Michael Alford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Alford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Alford. The network helps show where Michael Alford may publish in the future.

Co-authorship network of co-authors of Michael Alford

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Alford. A scholar is included among the top collaborators of Michael Alford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Alford. Michael Alford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockenstein, Edward, Michael Mante, Michael Alford, et al.. (2005). High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels. Journal of Biological Chemistry. 280(38). 32957–32967. 85 indexed citations

Masliah, Eliezer, Edward Rockenstein, Anthony Adame, et al.. (2005). Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease. Neuron. 46(6). 857–868. 423 indexed citations

Tiraboschi, Pietro, L. A. Hansen, Michael Alford, et al.. (2002). Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease. Archives of General Psychiatry. 59(10). 946–946. 133 indexed citations

Veinbergs, Isaac, Emily Van Uden, Margaret Mallory, et al.. (2001). Role of Apolipoprotein E Receptors in Regulating the Differential in vivo Neurotrophic Effects of Apolipoprotein E. Experimental Neurology. 170(1). 15–26. 31 indexed citations

Masliah, Eliezer, Michael Alford, Douglas Galasko, et al.. (2001). Cholinergic deficits in the brains of patients with parkinsonism–dementia complex of Guam. Neuroreport. 12(18). 3901–3903. 2 indexed citations

Masliah, Eliezer, et al.. (2000). Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice. Experimental Neurology. 163(2). 381–387. 116 indexed citations

Masliah, Eliezer, Jacob Raber, Michael Alford, et al.. (1998). Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport. Journal of Biological Chemistry. 273(20). 12548–12554. 45 indexed citations

Alford, Michael, et al.. (1997). Neurodegeneration of Somatostatin-immunoreactive Neurons in HIV Encephalitis. Journal of Neuropathology & Experimental Neurology. 56(4). 360–368. 63 indexed citations

Masliah, Eliezer, Lawrence A. Hansen, Michael Alford, Richard DeTeresa, & Margaret Mallory. (1996). Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease. Annals of Neurology. 40(5). 759–766. 379 indexed citations

10.

Chen, Xiaohua, Yu Xia, Michael Alford, et al.. (1995). The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease. Annals of Neurology. 38(4). 653–658. 32 indexed citations

11.

Mucke, Lennart, Carmela R. Abraham, Mary D. Ruppe, et al.. (1995). Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein.. The Journal of Experimental Medicine. 181(4). 1551–1556. 74 indexed citations

12.

Alford, Michael, Eliezer Masliah, L A Hansen, & Robert D. Terry. (1994). A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain.. Journal of Histochemistry & Cytochemistry. 42(2). 283–287. 57 indexed citations

13.

Mucke, Lennart, Eliezer Masliah, William B. Johnson, et al.. (1994). Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Research. 666(2). 151–167. 234 indexed citations

14.

Masliah, Eliezer, et al.. (1994). Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neuroscience Letters. 174(1). 67–72. 294 indexed citations

15.

Masliah, Eliezer, Margaret Mallory, Richard DeTeresa, Michael Alford, & Lawrence A. Hansen. (1993). Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Research. 617(2). 258–266. 49 indexed citations

16.

Langlais, P. J., L. Thai, Lawrence A. Hansen, et al.. (1993). Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 43(10). 1927–1927. 116 indexed citations

17.

Masliah, Eliezer, Margaret Mallory, Lawrence A. Hansen, et al.. (1992). Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease. Brain Research. 574(1-2). 312–316. 79 indexed citations

18.

Masliah, Eliezer, Margaret Mallory, Lawrence A. Hansen, et al.. (1991). Patterns of aberrant sprouting in alzheimer's disease. Neuron. 6(5). 729–739. 217 indexed citations

19.

Masliah, Eliezer, et al.. (1991). Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?. Annals of Neurology. 29(4). 389–396. 67 indexed citations

20.

Masliah, Eliezer, Robert D. Terry, Michael Alford, & Richard DeTeresa. (1990). Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections.. Journal of Histochemistry & Cytochemistry. 38(6). 837–844. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact